Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases

Sayan M., Zoto M., Sahin B., Kefelioglu E., Wang S., Kurup V., ...Daha Fazla

RADIATION ONCOLOGY JOURNAL, cilt.37, sa.4, ss.265-270, 2019 (Hakemli Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3857/roj.2019.00409
  • Dergi Adı: RADIATION ONCOLOGY JOURNAL
  • Sayfa Sayıları: ss.265-270
  • Anahtar Kelimeler: Radiosurgery, Radioresistant, Renal cell carcinoma, Melanoma, Brain, RENAL-CELL CARCINOMA, RADIATION-THERAPY, MELANOMA, RADIOTHERAPY, TUMORS, MANAGEMENT, SURGERY
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Purpose: Renal cell carcinoma (RCC) and melanoma have been considered 'radioresistant' due to the fact that they do not respond to conventionally fractionated radiation therapy. Stereotactic radiosurgery (SRS) provides high-dose radiation to a defined target volume and a limited number of studies have suggested the potential effectiveness of SRS in radioresistant histologies. We sought to determine the effectiveness of SRS for the treatment of patients with radioresistant brain metastases.